Entheon Biomedical Corp.
ENBI
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.70% | 97.66% | -61.64% | -39.93% | -38.81% |
| Total Receivables | 170.00% | -12.50% | -34.78% | -62.50% | -42.31% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -3.00% | -17.33% | -15.62% | -58.65% | -50.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 34.23% | 82.97% | -55.93% | -41.78% | -40.09% |
|
|
|||||
| Total Current Assets | 34.23% | 82.97% | -55.93% | -41.78% | -40.09% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.70% | -5.41% | -2.70% | -50.00% | -79.89% |
| Total Assets | 33.77% | 81.40% | -55.30% | -41.94% | -41.85% |
|
|
|||||
| Total Accounts Payable | -67.22% | 17.68% | -58.17% | -53.15% | -48.09% |
| Total Accrued Expenses | 216.67% | 7.69% | 380.00% | -23.81% | -92.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -61.64% | 17.02% | -54.85% | -51.14% | -53.44% |
|
|
|||||
| Total Current Liabilities | -61.64% | 17.02% | -54.85% | -51.14% | -53.44% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -61.64% | 17.02% | -54.85% | -51.14% | -53.44% |
|
|
|||||
| Common Stock & APIC | 1.89% | -2.90% | -2.41% | 3.98% | 3.24% |
| Retained Earnings | 3.49% | 7.33% | 4.87% | -4.76% | -4.18% |
| Treasury Stock & Other | -57.83% | -45.62% | -43.98% | 3.13% | 2.32% |
| Total Common Equity | 47.21% | 95.10% | -55.42% | -40.96% | -39.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 47.21% | 95.10% | -55.42% | -40.96% | -39.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 47.21% | 95.10% | -55.42% | -40.96% | -39.70% |
|
|
|||||